Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma

BACKGROUND: The overall 5-year survival of lung cancer was reported to be only ~15%, with lung adenocarcinoma (LUAD) as the main pathological subtype. Before developing into invasive stages, LUAD undergoes pre-invasive stages of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yue, Shang, Jun, Gao, Jian, Han, Han, Gao, Zhendong, Yan, Yueren, Zheng, Qiang, Ye, Ting, Fu, Fangqiu, Deng, Chaoqiang, Ma, Zelin, Zhang, Yang, Zheng, Difan, Zheng, Shanbo, Li, Yuan, Cao, Zhiwei, Shi, Leming, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283781/
https://www.ncbi.nlm.nih.gov/pubmed/35844495
http://dx.doi.org/10.3389/fimmu.2022.921761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283781/
https://www.ncbi.nlm.nih.gov/pubmed/35844495
http://dx.doi.org/10.3389/fimmu.2022.921761

Ejemplares similares